Ten years of dengue drug discovery: Progress and prospects

Keyphrases

• AG129 20%
• Animal Safety 20%
• Balapiravir 20%
• Celgosivir 20%
• Clinic Trial 20%
• Clinical Efficacy 20%
• Clinical Trials 20%
• Dengue 20%
• Dengue Drug Discovery 100%
• Dengue Virus 100%
• Development Board 20%
• Developmental Processes 20%
• Economic Development 20%
• Enzyme Assay 20%
• Hepatitis C Virus Inhibitors 20%
• High-throughput Screening 40%
• Hit Discovery 20%
• Hit-to-lead Optimization 20%
• Host Cell Proteins 20%
• In Silico Docking 20%
• Major Discoveries 20%
• Mosquito-borne 20%
• Mouse Model 20%
• Neglected Diseases 20%
• Novartis 80%
• Nucleoside Analogues 20%
• Pharmacokinetic Properties 20%
• Physicochemical Properties 20%
• Public Funding 20%
• Public-private 20%
• Rational Design 20%
• Replication Assay 20%
• Repurposing 20%
• Safety Study 20%
• Singapore 20%
• Tropical Diseases 60%
• Viral Enzymes 20%
• Viral Pathogens 20%
• Viral Proteins 20%
• Virus Replication 20%
• α-glucosidase Inhibitor 20%

Pharmacology, Toxicology and Pharmaceutical Science

• Alpha-Glucosidase Inhibitor 20%
• Antivirus Agent 40%
• Balapiravir 20%
• Castanospermine 6 Butyrate 20%
• Clinical Trial 20%
• Dengue 100%
• Dengue Virus 100%
• Drug Discovery 100%
• Hepatitis C Virus 20%
• High-Throughput Screening 40%
• Infectious Agent 20%
• Mouse Model 20%
• Neglected Disease 20%
• Nucleoside Analog 20%
• Pharmacokinetics 20%
• Repurposing 20%
• Synapsin I 20%
• Tropical Disease 60%